SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing significant volatility as investors debate whether the stock is being dragged down by broader sector rotation and delivery concerns or if institutional accumulation is occurring at key technical support levels. The community is sharply divided, with bulls pointing to long-term potential in AI and robotics, while bears are emphasizing weak delivery figures and the potential distraction of an upcoming SpaceX IPO.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. It offers Alpha, Beta, Gamma, and orbital transfer vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 27, 2017 and is headquartered in Cedar Park, TX.

Firefly Aerospace Inc.

Firefly Aerospace is trending as traders closely monitor the upcoming Alpha Flight 7 mission following multiple launch delays, while market attention is also focused on the highly anticipated quarterly financial report. The community is actively debating the stock's potential as a long-term space infrastructure play, weighing institutional interest in lunar lander exposure and AI-integrated orbital processing against the risks of execution delays and volatility.

Applied Digital Corporation

Applied Digital is trending following a massive fiscal third-quarter revenue beat that exceeded analyst expectations and confirmed strong HPC hosting demand. While investors are highly bullish on the long-term infrastructure thesis and scaling capacity, the community is closely monitoring the company's debt profile and waiting for confirmation on new hyperscaler lease signings to drive the next leg of growth.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is surging as investors react to the FDA accepting its resubmitted Biologics License Application for its lead skin cancer drug, RP1. The community is actively debating the likelihood of approval versus the risk of another rejection, with many traders closely monitoring high short interest and speculative volume ahead of the new April decision date.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending as investors rally ahead of the upcoming ES9 SUV debut, fueling optimism for a potential breakout alongside signs of strong battery-swapping growth. While bullish sentiment is bolstered by new product reveals and the expansion of proprietary AI technology, the stock remains a point of contention with ongoing debates between retail advocates targeting double-digit prices and short sellers questioning the company's long-term sustainability.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is gaining momentum as market participants debate its role as a long-standing satirical project, with the community actively highlighting its 2011 origins and historical connection to the broader crypto ecosystem. Supporters are framing the asset as a resilient cultural narrative that differentiates itself from newer, short-lived tokens by emphasizing its deep-rooted history and unique place in the parody space.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is currently trending as investors monitor the regulatory path for AXS-05 following the company's recent supplemental NDA submission for Alzheimer's disease agitation. The community is actively discussing the stock's recent ascent toward all-time highs and debating the potential impact of an anticipated priority review, while analysts continue to adjust price targets upward based on strong commercial momentum from Auvelity.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics Holdings is trending as investors react to the company securing European CE Mark approval for its one-year Eversense 365 CGM system. While the long-term technology potential drives excitement, the community remains divided over management's execution, historical cash burn, and the potential for further share dilution.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is trending as investors rotate into value-oriented dividend stocks, further buoyed by the FDA's recent acceptance and priority review of its combination therapy for multiple myeloma. The market is also closely monitoring the company's aggressive R&D expansion, including a new Janux Therapeutics partnership and ongoing clinical trials in its cardiovascular and oncology portfolios.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is seeing significant investor attention following a strong quarterly earnings report that highlighted increased operational EBITDA and revenue growth. The community is actively discussing the company's strategic pivot toward advanced materials, chemical manufacturing, and its potential role in domestic pharmaceutical supply chains, with many debating the impact of new trade tariffs and speculative government partnerships.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ANNX Hoping for more transparent updates soon on the forward study. They should have atleast gave a target enrollment date.

Frank Herrmann

jake the snake

StockTwits Web

Annexon Inc

 Hoping for more transparent updates soon on the forward study. They should have atleast gave a target enrollment date.

Instacart

Moderna Inc

Super Micro Computer Inc

Sarepta Therapeutics Inc

Rivian Automotive Inc

ACRIVON THERAPEUTICS INC

Stockwatcher9999

@Stockwatcher9999 can’t seem to break $6 and hold
Pathetic

StockTwits for iOS

 can’t seem to break $6 and hold
Pathetic